Center For Medicines In The Publicinterest

Programs: The organization participated in conferences and meetings including: pharmacovigilance seminar at health canada, fda science advisory board meeting on opioids in washington, dc, conference on abuse deterrent opioids in washington, dc, conference on regulatory convergence in paris, france, conference on pharmaceutical quality in beirut, lebanon, massbio conference, meetings on drug quality at panama ministry of health, conference on hta and precision medicine in london, fdli conference in washington, dc, off-label promotion conference , fda adcomm on opioids in washington, dc, meetings on drug quality at indonesia ministry of health, panel on the crisis in pharma communications in new york city, fda advisory committee meeting on biosimilars, meeting with argentina's ministry of health on 21st century medicines regulation, fda meeting on pdufa vi letter, bioethics international roundtable on clinical trial transparency, meeting with fda commissioner in washington, dc, meeting with singapore ministry of health, medical device conference in san diego, ca, international society of pharmacovigilance conference.

research reports: cmpi conducts research which addresses recommendations to establish new pathways for the faster commercialization of tools and technologies that deliver personalized medicine and promote american competitiveness in medical innovation. Published reports in 2016 include: not at any price: how icer robs myeloma patients of life and hope; 360 degree global trade and the urgent need for the trans-pacific partnership.